{"id":6640,"date":"2025-05-20T03:56:41","date_gmt":"2025-05-20T01:56:41","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/"},"modified":"2025-05-20T03:56:41","modified_gmt":"2025-05-20T01:56:41","slug":"les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/","title":{"rendered":"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l&rsquo;arr\u00eat de la nicotine"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2022\/quit-smoking.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/hires\/2022\/quit-smoking.jpg\" data-sub-html=\"Credit: Pixabay\/CC0 Public Domain\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>De nouvelles recherches pr\u00e9sent\u00e9es le 17 mai lors de la r\u00e9union annuelle de l&rsquo;American Psychiatric Association montrent que les agonistes des r\u00e9cepteurs du GLP-1 peuvent \u00eatre en mesure d&rsquo;aider les fumeurs de cigarettes \u00e0 r\u00e9duire la prise de poids pendant qu&rsquo;ils quittent.<\/p>\n<p>Une \u00e9quipe dirig\u00e9e par Debora Xavier, MD, a effectu\u00e9 une revue syst\u00e9matique et une m\u00e9ta-analyse pour d\u00e9terminer comment l&rsquo;abstinence des cigarettes et le gain de poids post-transformation ont \u00e9t\u00e9 affect\u00e9s par la pr\u00e9sence d&rsquo;agents des agonistes des r\u00e9cepteurs du peptide-1 de type glucagon (GLP-1RA). Traditionnellement utilis\u00e9 pour traiter le diab\u00e8te de type 2 et l&rsquo;ob\u00e9sit\u00e9, les agents GLP-1RA peuvent jouer un r\u00f4le dans la physiopathologie de la d\u00e9pendance.<\/p>\n<p>Une revue de la litt\u00e9rature a fait surface trois essais contr\u00f4l\u00e9s randomis\u00e9s qui r\u00e9pondaient aux crit\u00e8res d&rsquo;inclusion, repr\u00e9sentant 410 patients et 207 utilisateurs de GLP-1RA. Pour ceux qui se sont abstenus de cigarettes, les GLP-1RA ont consid\u00e9rablement r\u00e9duit le gain de poids apr\u00e8s l&rsquo;\u00e9laboration; Les utilisateurs de GLP-1RA ont perdu du poids tandis que les groupes de contr\u00f4le ont pris du poids. Les implications de l&rsquo;\u00e9tude sont encourageantes, \u00e9tant donn\u00e9 que le tabagisme est la principale cause de maladies et de d\u00e9c\u00e8s \u00e9vitables aux \u00c9tats-Unis<\/p>\n<p>\u00ab\u00a0Les agonistes des r\u00e9cepteurs du GLP-1 peuvent offrir une voie prometteuse pour aider les fumeurs \u00e0 quitter en r\u00e9pondant \u00e0 l&rsquo;une de leurs plus grandes pr\u00e9occupations: la prise de poids\u00a0\u00bb, a d\u00e9clar\u00e9 le Dr Xavier. \u00ab\u00a0Leurs effets de neuromodulation peuvent potentiellement r\u00e9duire les effets enrichissants de la nicotine et de la nourriture.\u00a0\u00bb<\/p>\n<p>Les chercheurs notent \u00e9galement que l&rsquo;efficacit\u00e9 \u00e0 long terme des GLP-1 sur l&rsquo;arr\u00eat du tabagisme est relativement modeste, en particulier en raison des envies et de la prise de poids qui peuvent survenir apr\u00e8s l&rsquo;arr\u00eat.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>De nouvelles recherches pr\u00e9sent\u00e9es le 17 mai lors de la r\u00e9union annuelle de l&rsquo;American Psychiatric<\/p>\n","protected":false},"author":1,"featured_media":2268,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[4298,16,2284,153,49,1122,92,3649,3514],"class_list":["post-6640","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-addictions","tag-agonistes","tag-des","tag-glp1","tag-larret","tag-les","tag-nicotine","tag-peuvent","tag-recepteurs","tag-soutenir","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l&#039;arr\u00eat de la nicotine - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l&#039;arr\u00eat de la nicotine - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"De nouvelles recherches pr\u00e9sent\u00e9es le 17 mai lors de la r\u00e9union annuelle de l&rsquo;American Psychiatric\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-20T01:56:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1279\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l&rsquo;arr\u00eat de la nicotine\",\"datePublished\":\"2025-05-20T01:56:41+00:00\",\"dateModified\":\"2025-05-20T01:56:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/\"},\"wordCount\":343,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg\",\"keywords\":[\"agonistes\",\"des\",\"GLP1\",\"larr\u00eat\",\"Les\",\"nicotine\",\"peuvent\",\"r\u00e9cepteurs\",\"soutenir\"],\"articleSection\":[\"Les addictions\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/\",\"name\":\"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l'arr\u00eat de la nicotine - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg\",\"datePublished\":\"2025-05-20T01:56:41+00:00\",\"dateModified\":\"2025-05-20T01:56:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg\",\"width\":1920,\"height\":1279,\"caption\":\"La var\u00e9nicline, une pilule pour arr\u00eater de fumer, sera propos\u00e9e par le NHS du Royaume-Uni\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l&rsquo;arr\u00eat de la nicotine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l'arr\u00eat de la nicotine - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/","og_locale":"fr_FR","og_type":"article","og_title":"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l'arr\u00eat de la nicotine - RVH-Synergie.org","og_description":"De nouvelles recherches pr\u00e9sent\u00e9es le 17 mai lors de la r\u00e9union annuelle de l&rsquo;American Psychiatric","og_url":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/","og_site_name":"RVH-Synergie","article_published_time":"2025-05-20T01:56:41+00:00","og_image":[{"width":1920,"height":1279,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l&rsquo;arr\u00eat de la nicotine","datePublished":"2025-05-20T01:56:41+00:00","dateModified":"2025-05-20T01:56:41+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/"},"wordCount":343,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg","keywords":["agonistes","des","GLP1","larr\u00eat","Les","nicotine","peuvent","r\u00e9cepteurs","soutenir"],"articleSection":["Les addictions"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/","url":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/","name":"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l'arr\u00eat de la nicotine - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg","datePublished":"2025-05-20T01:56:41+00:00","dateModified":"2025-05-20T01:56:41+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/11\/1732082176_La-varenicline-une-pilule-pour-arreter-de-fumer-sera-proposee.jpg","width":1920,"height":1279,"caption":"La var\u00e9nicline, une pilule pour arr\u00eater de fumer, sera propos\u00e9e par le NHS du Royaume-Uni"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/les-agonistes-des-recepteurs-glp-1-peuvent-soutenir-larret-de-la-nicotine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"Les agonistes des r\u00e9cepteurs GLP-1 peuvent soutenir l&rsquo;arr\u00eat de la nicotine"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/6640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=6640"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/6640\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/2268"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=6640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=6640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=6640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}